European Parliament Releases Draft Report on the Proposal for the Regulation of Plants Obtained from New Genomic Techniques
- Draft report supports the
European Commissionproposal to introduce a new regulation on plants obtained by certain new genomic techniques (NGTs) and their food and feed
- Proposed regulation identifies a ‘Conventional-like’ category of NGT products that would be regulated as conventional varieties, bringing EU policy closer to that of trading partners in
North and South America, Australia, and Japan
- Report states that new genomic techniques have the ability to enhance agriculture by making crops more resilient and sustainable whilst providing unprecedented opportunities for European agriculture and food production
- Under the proposal, products from Cibus’ gene editing platform such as canola and oilseed rape resistant to disease or with reduced seed losses would be considered ‘Conventional-like'
The proposal describes a category of NGTs producing modifications that could be obtained in nature or by conventional breeding. These are determined to be ‘Conventional-like’ and would be regulated in the same way as conventional varieties. The proposal was adopted by the
“We welcome the proposal from the
The draft report, published by the
The draft report recognizes the Commission proposal as a solid starting point and recommends further improvements to ensure the best possible usage of the techniques in the EU. These include clarification of the criteria for conventional-like NGT plants, freedom of choice for organic farmers to use NGTs plants and ensuring a science-based verification procedure.
The Committee is aiming to finalise its report by
Source: Draft Report from European Parliament ENVI Committee Rapporteur can be found here via the following link:
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability areas for farmers such as diseases and pests which the
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding the benefits of the Act, Cibus’ operational performance, and Cibus’ strategy, future operations, prospects and plans, are forward-looking statements. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “intend”, “expect,” “plan,” “scheduled,” “could,” “would” and “will,” or the negative of these and similar expressions.
These forward-looking statements are based on the current expectations and assumptions of Cibus’ management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. There are many factors that could cause Cibus’ actual results, level of activity, performance or achievements to differ materially from those expressed or implied by forward-looking statements, including factors related to: (i) risks associated with the possible failure to realize certain anticipated benefits of the transactions contemplated by the merger (the “Transactions”), including with respect to future financial and operating results; (ii) the effect of the completion of the Transactions on Cibus’ business relationships, operating results and business generally; (iii) the outcome of any litigation related to the merger agreement or Transactions; (iv) competitive responses to the Transactions and changes in expected or existing competition; (v) challenges to Cibus’ intellectual property protection and unexpected costs associated with defending Cibus’ intellectual property rights; (vi) increased or unanticipated time and resources required for Cibus’ platform or trait product development efforts; (vii) Cibus’ reliance on third parties in connection with its development activities; (viii) Cibus’ ability to effectively license its productivity traits and sustainable ingredient products; (ix) the recognition of value in Cibus’ products by farmers, and the ability of farmers and processors to work effectively with crops containing Cibus’ traits; (x) Cibus’ ability to produce high-quality plants and seeds cost effectively on a large scale; (xi) Cibus’ need for additional funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all; (xii) Cibus’ dependence on distributions from
Cibus US LLC